Concepedia

Publication | Open Access

Serum YKL-40 Independently Predicts Outcome after Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma

DOIFull Paper Access

19

Citations

18

References

2012

Year

Cheng‐Bao Zhu, Can Wang, Lili Chen, Guo-Liang Ma, Shicai Zhang, Liang Su, Jianjun Paul Tian, Zhongtao Gai
PLoS ONE

Abstract

Serum YKL-40 was demonstrated to be an independent prognostic biomarker in HCC patients treated with TACE. Our results need confirmation in an independent study.

References

YearCitations

Page 1